| Neurological adverse events of new generation sodium blocker antiepileptic drugs. Meta-analysis of randomized, double-blinded studies with eslicarbazepine acetate, lacosamide … G Zaccara, F Giovannelli, D Maratea, V Fadda, A Verrotti Seizure 22 (7), 528-536, 2013 | 84 | 2013 |
| Results can be summarised in a simple figure V Fadda, D Maratea, S Trippoli, A Messori BMJ: British Medical Journal (Online) 342, 2011 | 41 | 2011 |
| ω-3 fatty acid supplements for secondary prevention of cardiovascular disease: from “no proof of effectiveness” to “proof of no effectiveness” A Messori, V Fadda, D Maratea, S Trippoli JAMA internal medicine 173 (15), 1466-1468, 2013 | 40 | 2013 |
| Treatments for relapsing–remitting multiple sclerosis: summarising current information by network meta-analysis F Del Santo, D Maratea, V Fadda, S Trippoli, A Messori European journal of clinical pharmacology 68, 441-448, 2012 | 40 | 2012 |
| Stent-retriever thrombectomy for stroke OA Berkhemer, WH van Zwam, DW Dippel, MR CLEAN Investigators N Engl J Med 373 (11), 1076, 2015 | 31 | 2015 |
| Nephrotoxicity of different formulations of amphotericin B: summarizing evidence by network meta-analysis A Messori, V Fadda, D Maratea, S Trippoli, C Marinai Clinical infectious diseases 57 (12), 1783-1784, 2013 | 27 | 2013 |
| Testing the therapeutic equivalence of alogliptin, linagliptin, saxagliptin, sitagliptin or vildagliptin as monotherapy or in combination with metformin in patients with type 2 … A Messori, V Fadda, D Maratea, S Trippoli, C Marinai Diabetes Therapy 5, 341-344, 2014 | 25 | 2014 |
| Prevention of venous thromboembolism after major orthopedic surgery: indirect comparison of three new oral anticoagulants D Maratea, V Fadda, S Trippoli, A Messori Journal of Thrombosis and Haemostasis 9 (9), 1868-1870, 2011 | 25 | 2011 |
| Temporal trend of short-term mortality in severely ill patients receiving parenteral glutamine supplementation V Fadda, D Maratea, S Trippoli, A Messori Clinical Nutrition 32 (3), 492-493, 2013 | 24 | 2013 |
| Using risk difference as opposed to odds-ratio in meta-analysis A Messori, D Maratea, V Fadda, S Trippoli International journal of cardiology 164 (1), 127, 2013 | 16 | 2013 |
| Valutazione di costo-efficacia dei nuovi farmaci oncologici immessi sul mercato italiano N Martone, C Lucioni, S Mazzi, V Fadda Glob Reg Heal Technol Assess 1, 31-43, 2014 | 15 | 2014 |
| Acute lymphoblastic leukemia in first complete remission: temporal trend of outcomes in studies comparing allogeneic transplant with autologous transplant or chemotherapy A Messori, V Fadda, D Maratea, S Trippoli Annals of hematology 92 (9), 1221-1228, 2013 | 15 | 2013 |
| Anti-platelet treatments in acute coronary syndrome: simplified network meta-analysis D Passaro, V Fadda, D Maratea, A Messori International journal of cardiology 150 (3), 364-367, 2011 | 15 | 2011 |
| Erythropoiesis‐stimulating agents in heart failure: no proof of effectiveness or proof of no effectiveness? A Messori, V Fadda, D Maratea, S Trippoli European journal of heart failure 15 (8), 944-945, 2013 | 14 | 2013 |
| Treatments for macular degeneration: summarising evidence using network meta-analysis V Fadda, D Maratea, S Trippoli, A Messori British Journal of Ophthalmology 95 (10), 1476-1477, 2011 | 12 | 2011 |
| First-line treatments for chronic lymphocytic leukaemia: interpreting efficacy data by network meta-analysis A Messori, V Fadda, D Maratea, S Trippoli Annals of Hematology 94 (6), 1003-1009, 2015 | 11 | 2015 |
| Intravenous proton pump inhibitors for stress ulcer prophylaxis in critically ill patients: determining statistical equivalence according to evidence-based methods A Messori, V Fadda, D Maratea, R Gatto, S Trippoli, M De Rosa, C Marinai Int J Clin Pharmacol Ther 52 (10), 825-829, 2014 | 11 | 2014 |
| Anti-reabsorptive agents in women with osteoporosis: determining statistical equivalence according to evidence-based methods A Messori, V Fadda, D Maratea, S Trippoli, C Marinai Journal of Endocrinological Investigation 37, 769-773, 2014 | 11 | 2014 |
| Nationwide prediction of future expenditure for protease inhibitors in chronic hepatitis C D Maratea, A Messori, V Fadda Digestive and Liver Disease 44 (1), 86-87, 2012 | 11 | 2012 |
| Effectiveness and Cost Effectiveness of Bevacizumab in Metastatic Colorectal Cancer. A Messori, M De Rosa, V Fadda, L Pani Journal of Clinical Oncology: Official Journal of the American Society of …, 2015 | 10 | 2015 |
